Details for Patent: 8,846,100
✉ Email this page to a colleague
Which drugs does patent 8,846,100 protect, and when does it expire?
Patent 8,846,100 protects MYDAYIS and is included in one NDA.
Summary for Patent: 8,846,100
Title: | Controlled dose drug delivery system |
Abstract: | A multiple pulsed dose drug delivery system for pharmaceutically active amphetamine salts, comprising a pharmaceutically active amphetamine salt covered with an immediate-release coating and a pharmaceutically active amphetamine salt covered with an enteric coating wherein the immediate release coating and the enteric coating provide for multiple pulsed dose delivery of the pharmaceutically active amphetamine salt. The product can be composed of either one or a number of beads in a dosage form, including either capsule, tablet, or sachet method for administering the beads. |
Inventor(s): | Shojaei; Amir (Phoenixville, PA), Read; Stephanie (Philadelphia, PA), Couch; Richard A. (Bryn Mawr, PA), Hodgkins; Paul (Exton, PA) |
Assignee: | Shire LLC (Florence, KY) |
Application Number: | 11/383,066 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,846,100 |
Patent Claim Types: see list of patent claims | Composition; |